Cargando…
Novel Antibodies for the Simple and Efficient Enrichment of Native O-GlcNAc Modified Peptides
Antibodies against posttranslational modifications (PTMs) such as lysine acetylation, ubiquitin remnants, or phosphotyrosine have resulted in significant advances in our understanding of the fundamental roles of these PTMs in biology. However, the roles of a number of PTMs remain largely unexplored...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605273/ https://www.ncbi.nlm.nih.gov/pubmed/34678516 http://dx.doi.org/10.1016/j.mcpro.2021.100167 |
_version_ | 1784602143235244032 |
---|---|
author | Burt, Rajan A. Dejanovic, Borislav Peckham, Hayley J. Lee, Kimberly A. Li, Xiang Ounadjela, Johain R. Rao, Anjana Malaker, Stacy A. Carr, Steven A. Myers, Samuel A. |
author_facet | Burt, Rajan A. Dejanovic, Borislav Peckham, Hayley J. Lee, Kimberly A. Li, Xiang Ounadjela, Johain R. Rao, Anjana Malaker, Stacy A. Carr, Steven A. Myers, Samuel A. |
author_sort | Burt, Rajan A. |
collection | PubMed |
description | Antibodies against posttranslational modifications (PTMs) such as lysine acetylation, ubiquitin remnants, or phosphotyrosine have resulted in significant advances in our understanding of the fundamental roles of these PTMs in biology. However, the roles of a number of PTMs remain largely unexplored due to the lack of robust enrichment reagents. The addition of N-acetylglucosamine to serine and threonine residues (O-GlcNAc) by the O-GlcNAc transferase (OGT) is a PTM implicated in numerous biological processes and disease states but with limited techniques for its study. Here, we evaluate a new mixture of anti-O-GlcNAc monoclonal antibodies for the immunoprecipitation of native O-GlcNAcylated peptides from cells and tissues. The anti-O-GlcNAc antibodies display good sensitivity and high specificity toward O-GlcNAc-modified peptides and do not recognize O-GalNAc or GlcNAc in extended glycans. Applying this antibody-based enrichment strategy to synaptosomes from mouse brain tissue samples, we identified over 1300 unique O-GlcNAc-modified peptides and over 1000 sites using just a fraction of sample preparation and instrument time required in other landmark investigations of O-GlcNAcylation. Our rapid and robust method greatly simplifies the analysis of O-GlcNAc signaling and will help to elucidate the role of this challenging PTM in health and disease. |
format | Online Article Text |
id | pubmed-8605273 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Society for Biochemistry and Molecular Biology |
record_format | MEDLINE/PubMed |
spelling | pubmed-86052732021-11-24 Novel Antibodies for the Simple and Efficient Enrichment of Native O-GlcNAc Modified Peptides Burt, Rajan A. Dejanovic, Borislav Peckham, Hayley J. Lee, Kimberly A. Li, Xiang Ounadjela, Johain R. Rao, Anjana Malaker, Stacy A. Carr, Steven A. Myers, Samuel A. Mol Cell Proteomics Technological Innovation and Resources Antibodies against posttranslational modifications (PTMs) such as lysine acetylation, ubiquitin remnants, or phosphotyrosine have resulted in significant advances in our understanding of the fundamental roles of these PTMs in biology. However, the roles of a number of PTMs remain largely unexplored due to the lack of robust enrichment reagents. The addition of N-acetylglucosamine to serine and threonine residues (O-GlcNAc) by the O-GlcNAc transferase (OGT) is a PTM implicated in numerous biological processes and disease states but with limited techniques for its study. Here, we evaluate a new mixture of anti-O-GlcNAc monoclonal antibodies for the immunoprecipitation of native O-GlcNAcylated peptides from cells and tissues. The anti-O-GlcNAc antibodies display good sensitivity and high specificity toward O-GlcNAc-modified peptides and do not recognize O-GalNAc or GlcNAc in extended glycans. Applying this antibody-based enrichment strategy to synaptosomes from mouse brain tissue samples, we identified over 1300 unique O-GlcNAc-modified peptides and over 1000 sites using just a fraction of sample preparation and instrument time required in other landmark investigations of O-GlcNAcylation. Our rapid and robust method greatly simplifies the analysis of O-GlcNAc signaling and will help to elucidate the role of this challenging PTM in health and disease. American Society for Biochemistry and Molecular Biology 2021-10-20 /pmc/articles/PMC8605273/ /pubmed/34678516 http://dx.doi.org/10.1016/j.mcpro.2021.100167 Text en © 2021 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Technological Innovation and Resources Burt, Rajan A. Dejanovic, Borislav Peckham, Hayley J. Lee, Kimberly A. Li, Xiang Ounadjela, Johain R. Rao, Anjana Malaker, Stacy A. Carr, Steven A. Myers, Samuel A. Novel Antibodies for the Simple and Efficient Enrichment of Native O-GlcNAc Modified Peptides |
title | Novel Antibodies for the Simple and Efficient Enrichment of Native O-GlcNAc Modified Peptides |
title_full | Novel Antibodies for the Simple and Efficient Enrichment of Native O-GlcNAc Modified Peptides |
title_fullStr | Novel Antibodies for the Simple and Efficient Enrichment of Native O-GlcNAc Modified Peptides |
title_full_unstemmed | Novel Antibodies for the Simple and Efficient Enrichment of Native O-GlcNAc Modified Peptides |
title_short | Novel Antibodies for the Simple and Efficient Enrichment of Native O-GlcNAc Modified Peptides |
title_sort | novel antibodies for the simple and efficient enrichment of native o-glcnac modified peptides |
topic | Technological Innovation and Resources |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605273/ https://www.ncbi.nlm.nih.gov/pubmed/34678516 http://dx.doi.org/10.1016/j.mcpro.2021.100167 |
work_keys_str_mv | AT burtrajana novelantibodiesforthesimpleandefficientenrichmentofnativeoglcnacmodifiedpeptides AT dejanovicborislav novelantibodiesforthesimpleandefficientenrichmentofnativeoglcnacmodifiedpeptides AT peckhamhayleyj novelantibodiesforthesimpleandefficientenrichmentofnativeoglcnacmodifiedpeptides AT leekimberlya novelantibodiesforthesimpleandefficientenrichmentofnativeoglcnacmodifiedpeptides AT lixiang novelantibodiesforthesimpleandefficientenrichmentofnativeoglcnacmodifiedpeptides AT ounadjelajohainr novelantibodiesforthesimpleandefficientenrichmentofnativeoglcnacmodifiedpeptides AT raoanjana novelantibodiesforthesimpleandefficientenrichmentofnativeoglcnacmodifiedpeptides AT malakerstacya novelantibodiesforthesimpleandefficientenrichmentofnativeoglcnacmodifiedpeptides AT carrstevena novelantibodiesforthesimpleandefficientenrichmentofnativeoglcnacmodifiedpeptides AT myerssamuela novelantibodiesforthesimpleandefficientenrichmentofnativeoglcnacmodifiedpeptides |